Current Duke Appointments & Affiliations
Assistant Professor of Medicine
·
2021 - Present
Medicine, Hematologic Malignancies and Cellular Therapy,
Medicine
Recent Grants
A Phase¿3, randomized, open-label study of belantamab mafodotin, administered in combination with lenalidomide, and dexamethasone (BRd) versus daratumumab, lenalidomide, and dexamethasone (DRd) in participants with newly diagnosed multiple myeloma
Clinical TrialPrincipal Investigator · Awarded by GlaxoSmithKline Research and Development Limited · 2025 - 2030View All Grants
Education
Duke University, School of Medicine ·
2015
M.D.